GSK3β and the control of infectious bacterial diseases.

Glycogen synthase kinase 3β (GSK3β) has been shown to be a crucial mediator of the intensity and direction of the innate immune system response to bacterial stimuli. This review focuses on: (i) the central role of GSK3β in the regulation of pathogen-induced inflammatory responses through the regulation of pro- and anti-inflammatory cytokine production, (ii) the extensive ongoing efforts to exploit GSK3β for its therapeutic potential in the control of infectious diseases, and (iii) the increasing evidence that specific pathogens target GSK3β-related pathways for immune evasion. A better understanding of complex bacteria-GSK3β interactions is likely to lead to more effective anti-inflammatory interventions and novel targets to circumvent pathogen colonization and survival.

[1]  P. Sandy,et al.  Glycogen Synthase Kinase-3β Regulates NF-κB1/p105 Stability* , 2003, Journal of Biological Chemistry.

[2]  Michael Martin,et al.  Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. , 2011, Cytokine.

[3]  S. Foster,et al.  GSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat* , 2005, Critical care medicine.

[4]  J. Torday,et al.  Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts , 2011, Experimental lung research.

[5]  B. Finlay,et al.  The Phosphoinositide-3-Kinase–Akt Signaling Pathway Is Important for Staphylococcus aureus Internalization by Endothelial Cells , 2011, Infection and Immunity.

[6]  J. Bagaitkar,et al.  Cotinine inhibits the pro-inflammatory response initiated by multiple cell surface Toll-like receptors in monocytic THP cells , 2012, Tobacco induced diseases.

[7]  S. Atamanalp,et al.  Protective effects of lithium: a new look at an old drug with potential antioxidative and anti-inflammatory effects in an animal model of sepsis. , 2013, International immunopharmacology.

[8]  R. Schwabe,et al.  Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[9]  Seongheon Lee,et al.  Curcumin Protects Against Regional Myocardial Ischemia/Reperfusion Injury Through Activation of RISK/GSK-3β and Inhibition of p38 MAPK and JNK , 2012, Journal of cardiovascular pharmacology and therapeutics.

[10]  Gustavo Pedraza-Alva,et al.  Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation , 2008, Science.

[11]  F. Lang,et al.  PKB/SGK-dependent GSK3-phosphorylation in the regulation of LPS-induced Ca2+ increase in mouse dendritic cells. , 2013, Biochemical and biophysical research communications.

[12]  J. Clements,et al.  Minocycline Suppresses Activation of Nuclear Factor of Activated T Cells 1 (NFAT1) in Human CD4+ T Cells* , 2011, The Journal of Biological Chemistry.

[13]  P. Cossart,et al.  The Listeria monocytogenes Protein InlB Is an Agonist of Mammalian Phosphoinositide 3-Kinase* , 1999, The Journal of Biological Chemistry.

[14]  T. Meyer,et al.  Specific Entry of Helicobacter pylori into Cultured Gastric Epithelial Cells via a Zipper-Like Mechanism , 2002, Infection and Immunity.

[15]  C. Lang,et al.  Inhibition of Glycogen Synthase Kinase 3&bgr; Activity with Lithium In Vitro Attenuates Sepsis-Induced Changes in Muscle Protein Turnover , 2011, Shock.

[16]  P. Cohen,et al.  A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. , 2001, Molecular Cell.

[17]  Yee‐Shin Lin,et al.  Glycogen synthase kinase‐3 negatively regulates anti‐inflammatory interleukin‐10 for lipopolysaccharide‐induced iNOS/NO biosynthesis and RANTES production in microglial cells , 2009, Immunology.

[18]  Y. Nolan,et al.  GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia , 2012, Neurochemistry International.

[19]  Mosoka P. Fallah,et al.  Role of phosphoinositide 3-kinase–Akt signaling pathway in the age-related cytokine dysregulation in splenic macrophages stimulated via TLR-2 or TLR-4 receptors , 2011, Mechanisms of Ageing and Development.

[20]  P. Sandy,et al.  Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability. , 2003, The Journal of biological chemistry.

[21]  P. Cohen,et al.  Insulin activates protein kinase B, inhibits glycogen synthase kinase‐3 and activates glycogen synthase by rapamycin‐insensitive pathways in skeletal muscle and adipose tissue , 1997, FEBS letters.

[22]  Jun Sun,et al.  β-Catenin activity negatively regulates bacteria-induced inflammation , 2007, Laboratory Investigation.

[23]  R. Jotwani,et al.  Inhibition of GSK3 Abolishes Bacterial-Induced Periodontal Bone Loss in Mice , 2012, Molecular medicine.

[24]  Jue Fan,et al.  Glycogen synthase kinase‐3beta suppresses tumor necrosis factor‐alpha expression in cardiomyocytes during lipopolysaccharide stimulation , 2008, Journal of cellular biochemistry.

[25]  N. Sauvonnet,et al.  YopH prevents monocyte chemoattractant protein 1 expression in macrophages and T‐cell proliferation through inactivation of the phosphatidylinositoI 3‐kinase pathway , 2002, Molecular microbiology.

[26]  R. Jope,et al.  Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). , 2010, Trends in immunology.

[27]  D. Ganea,et al.  A Novel Signaling Pathway Mediates the Inhibition of CCL3/4 Expression by Prostaglandin E2* , 2004, Journal of Biological Chemistry.

[28]  J. Wu,et al.  Host Wnt/beta-catenin pathway triggered by Helicobacter pylori correlates with regression of gastric intestinal metaplasia after H. pylori eradication. , 2009, Journal of medical microbiology.

[29]  D. Green,et al.  GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. , 2004, Molecular cell.

[30]  K. Ochiai,et al.  Oral Porphyromonas gingivalis translocates to the liver and regulates hepatic glycogen synthesis through the Akt/GSK-3β signaling pathway. , 2013, Biochimica et biophysica acta.

[31]  Y. Qian,et al.  Neuroprotective Effects of Pretreatment with Propofol in LPS-Induced BV-2 Microglia Cells: Role of TLR4 and GSK-3β , 2012, Inflammation.

[32]  Carlos A. Garcia,et al.  IFN-β Production by TLR4-Stimulated Innate Immune Cells Is Negatively Regulated by GSK3-β1 , 2008, The Journal of Immunology.

[33]  Caglar Cekic,et al.  IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. , 2008, Journal of immunology.

[34]  David Steven Scott,et al.  Tobacco use increases susceptibility to bacterial infection , 2008, Tobacco induced diseases.

[35]  Joel Moss,et al.  Helicobacter pylori VacA-induced Inhibition of GSK3 through the PI3K/Akt Signaling Pathway* , 2009, Journal of Biological Chemistry.

[36]  J. Woodgett,et al.  IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. , 2006, Immunity.

[37]  M. Peppelenbosch,et al.  Kinase Activity Profiling of Gram-Negative Pneumonia , 2011, Molecular medicine.

[38]  R. Lamont,et al.  The Serine Phosphatase SerB of Porphyromonas gingivalis Suppresses IL-8 Production by Dephosphorylation of NF-κB RelA/p65 , 2013, PLoS pathogens.

[39]  J. Suttles,et al.  The Role of JAK-3 in Regulating TLR-Mediated Inflammatory Cytokine Production in Innate Immune Cells , 2013, The Journal of Immunology.

[40]  Pradeep Dewapriya,et al.  EGFR tyrosine kinase inhibitory peptide attenuates Helicobacter pylori-mediated hyper-proliferation in AGS enteric epithelial cells. , 2013, Toxicology and applied pharmacology.

[41]  David A. Brenner,et al.  Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes , 2002 .

[42]  Jun Sun,et al.  Beta‐catenin activity negatively regulates bacteria‐induced inflammation , 2007 .

[43]  S. Ramirez,et al.  Glycogen synthase kinase 3β inhibition prevents monocyte migration across brain endothelial cells via Rac1-GTPase suppression and down-regulation of active integrin conformation. , 2012, The American journal of pathology.

[44]  N. Zhang,et al.  S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β. , 2012, Experimental cell research.

[45]  J. Connor,et al.  Chapter 9 HijAkt The PI3K/Akt Pathway in Virus Replication and Pathogenesis , 2012, Progress in Molecular Biology and Translational Science.

[46]  Bill B. Chen,et al.  LPS Impairs Phospholipid Synthesis by Triggering β-Transducin Repeat-containing Protein (β-TrCP)-mediated Polyubiquitination and Degradation of the Surfactant Enzyme Acyl-CoA:Lysophosphatidylcholine Acyltransferase I (LPCAT1)* , 2010, The Journal of Biological Chemistry.

[47]  J. Engel,et al.  Pseudomonas aeruginosa exploits a PIP3-dependent pathway to transform apical into basolateral membrane , 2007, The Journal of cell biology.

[48]  A. Reith,et al.  The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. , 2001, Structure.

[49]  V. J. Cid,et al.  Addressing the effects of Salmonella internalization in host cell signaling on a reverse‐phase protein array , 2009, Proteomics.

[50]  Chul Hee Choi,et al.  Porphyromonas gingivalis‐nucleoside‐diphosphate‐kinase inhibits ATP‐induced reactive‐oxygen‐species via P2X7 receptor/NADPH‐oxidase signalling and contributes to persistence , 2013, Cellular microbiology.

[51]  H. Kang,et al.  Protein Kinase C δ (PKCδ)-Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling Cascade Regulates Glycogen Synthase Kinase-3 (GSK-3) Inhibition-mediated Interleukin-10 (IL-10) Expression in Lipopolysaccharide (LPS)-induced Endotoxemia* , 2012, The Journal of Biological Chemistry.

[52]  Chiou-Feng Lin,et al.  Staphylococcus aureus Induces Microglial Inflammation via a Glycogen Synthase Kinase 3β-Regulated Pathway , 2009, Infection and Immunity.

[53]  F. Takahashi‐Yanaga,et al.  Activator or inhibitor? GSK-3 as a new drug target. , 2013, Biochemical pharmacology.

[54]  T. Hirayama,et al.  Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA. , 2010, The Tohoku journal of experimental medicine.

[55]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.

[56]  K. Tracey.  Reflex control of immunity , 2009, Nature Reviews Immunology.

[57]  V. A. Palyulin,et al.  Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases , 2011, Parasitology.

[58]  Carlos A. Garcia,et al.  Toll-Like Receptor-Mediated Production of IL-1Ra Is Negatively Regulated by GSK3 via the MAPK ERK1/21 , 2009, The Journal of Immunology.

[59]  Jie-Oh Lee,et al.  Sensing of microbial molecular patterns by Toll‐like receptors , 2012, Immunological reviews.

[60]  P. Yan,et al.  Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts. , 2012, Molecular immunology.

[61]  R. Jope,et al.  Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 , 2005, Nature Immunology.

[62]  B. Finlay,et al.  The Salmonella Effector Protein SopB Protects Epithelial Cells from Apoptosis by Sustained Activation of Akt* , 2005, Journal of Biological Chemistry.

[63]  Yee‐Shin Lin,et al.  Regulatory Role of GSK-3β on NF-κB, Nitric Oxide, and TNF-α in Group A Streptococcal Infection , 2013, Mediators of inflammation.

[64]  K. Kawashima,et al.  Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function. , 2012, Life sciences.

[65]  H. Einsele,et al.  Role of glycogen synthase kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus. , 2010, Medical mycology.

[66]  B. Coombes,et al.  Identification of MEK‐ and phosphoinositide 3‐kinase‐dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells , 2002, Cellular microbiology.

[67]  J. Kalbfleisch,et al.  Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice. , 2006, American journal of physiology. Heart and circulatory physiology.

[68]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. , 2000, Nature.

[69]  N. Reiling,et al.  Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses. , 2011, European journal of cell biology.

[70]  G. Tyrrell,et al.  Invasion of HeLa cells by group B streptococcus requires the phosphoinositide-3-kinase signalling pathway and modulates phosphorylation of host-cell Akt and glycogen synthase kinase-3. , 2007, Microbiology.

[71]  R. Hay,et al.  betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. , 2003, Molecular and cellular biology.

[72]  A. Bejsovec,et al.  Cellular mechanisms of wingless/Wnt signal transduction. , 1999, Current topics in developmental biology.

[73]  E. Goldsmith,et al.  Yersinia YopJ Acetylates and Inhibits Kinase Activation by Blocking Phosphorylation , 2006, Science.

[74]  R. N. Saha,et al.  Regulation of inducible nitric oxide synthase gene in glial cells. , 2006, Antioxidants & redox signaling.

[75]  Jian-Dong Li.  Exploitation of host epithelial signaling networks by respiratory bacterial pathogens. , 2003, Journal of pharmacological sciences.

[76]  J. Wang-Rodriguez,et al.  Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt , 2012, BMC Cancer.

[77]  E. Petricoin,et al.  Anthrax infection inhibits the AKT signaling involved in the E-cadherin-mediated adhesion of lung epithelial cells , 2009, FEMS immunology and medical microbiology.

[78]  S. Michalek,et al.  Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. , 2009, Molecular immunology.

[79]  D. Renaud,et al.  Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells. , 2008, Biochimica et biophysica acta.

[80]  D. Kalman,et al.  RNAi Screen Reveals an Abl Kinase-Dependent Host Cell Pathway Involved in Pseudomonas aeruginosa Internalization , 2008, PLoS pathogens.

[81]  Q. Zhan,et al.  p90‐RSK and Akt may promote rapid phosphorylation/inactivation of glycogen synthase kinase 3 in chemoattractant‐stimulated neutrophils , 2001, FEBS letters.

[82]  P. Cohen,et al.  A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐catenin , 1999, FEBS letters.

[83]  B. Foxwell,et al.  Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human Macrophages , 2004, The Journal of Immunology.

[84]  P. Cleary,et al.  M1 Protein Triggers a Phosphoinositide Cascade for Group A Streptococcus Invasion of Epithelial Cells , 2003, Infection and Immunity.

[85]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[86]  A. Reith,et al.  The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation , 2001 .

[87]  K. Kehn-Hall,et al.  Modulation of GSK-3β Activity in Venezuelan Equine Encephalitis Virus Infection , 2012, PloS one.

[88]  R. Jope,et al.  Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3* , 2008, Journal of Biological Chemistry.

[89]  A. Ougolkov,et al.  Inhibition of glycogen synthase kinase-3. , 2008, Methods in molecular biology.

[90]  L. Samavati,et al.  STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. , 2009, Molecular immunology.

[91]  P. Singer,et al.  Inhaled Aerosolized Insulin: A “Topical” Anti-inflammatory Treatment for Acute Lung Injury and Respiratory Distress Syndrome? , 2010, Inflammation.

[92]  R. Hay,et al.  βTrCP-Mediated Proteolysis of NF-κB1 p105 Requires Phosphorylation of p105 Serines 927 and 932 , 2003, Molecular and Cellular Biology.